Related by context. All words. (Click for frequent words.) 60 recombinant soluble 59 orally bioavailable 59 irreversible inhibitor 59 GVAX ® 59 Liposomal 59 Micromet BiTE 59 non nucleoside inhibitor 58 PDE4 inhibitor 58 RNA antagonists 58 hyperimmune 58 TransVax tm 58 lipopeptide 58 BiTE R 58 valent pneumococcal 58 hyaluronidase enzyme 58 personalized dendritic 57 selective orally bioavailable 57 plasmid encoding 57 HCV polymerase 57 loaded dendritic cell 57 humanized monoclonal 56 mertansine 56 recombinant fusion 56 Maribavir 56 intranasal formulation 56 ChronVac C R 56 developing Zerenex ferric 56 PNP inhibitor 56 RiVax 56 Valtropin 56 oral prodrug 56 oral antiviral 56 thrombin receptor 56 orally administered inhibitor 56 IMA# 55 Arcelis ™ 55 NS5A inhibitor 55 acid phosphatase PAP 55 Neugene 55 generation purine nucleoside 55 vinorelbine tartrate 55 IMiDs R 55 generation antisense inhibitor 55 nasal powder 55 inhalation powder 55 selectively inhibits 55 immunotherapeutic vaccine 55 pegylated recombinant 55 targeted antifolate 55 humanised monoclonal antibody 55 virosome 55 dose escalation clinical 55 administered intramuscularly 55 adecatumumab MT# 55 TRX1 55 AAG geldanamycin analog 55 pan histone deacetylase 55 Intravenous Human 55 CRM# 55 chimeric monoclonal antibody 55 Pharmacokinetics PK 55 rPA anthrax vaccine 55 selective agonist 55 Intercell investigational 55 beta 1a 55 Intradermal 54 Factor VIIa 54 GLP toxicology studies 54 vectored vaccine 54 novel histone deacetylase 54 Luteinizing Hormone Releasing Hormone 54 Files Investigational 54 Kinase Inhibitor 54 Tetanus Toxoid 54 Phase #b/#a clinical 54 potently inhibited 54 Presents Preclinical Data 54 nasally administered 54 ABL inhibitor 54 potently inhibits 54 Topoisomerase II 54 selective estrogen receptor modulator 54 potent inducer 54 investigational oral inhibitor 54 Inactivated 54 KSP inhibitor 54 novel immunotherapeutic 54 5 HT2A serotonin 54 stem cell mobilizer 54 neuraminidase inhibitor 54 IMPDH inhibitor 54 volociximab 54 Daclizumab 54 Submits IND 54 investigational antibiotic 54 cathepsin K inhibitor 54 Adjuvanted 54 targeted radiotherapeutic 54 oral proteasome inhibitor 54 CYC# 54 selectively binds 54 isoform selective 54 anti botulism antibody 54 Initiates Phase II 54 toxoids 54 topoisomerase II inhibitor 54 enzyme inhibitor 54 orally inhaled 54 AmpliChip 54 Saquinavir 54 DURIN TM 54 Initiate Phase 53 poly ADP ribose polymerase 53 BiTE ® 53 cytotoxic T lymphocyte 53 Pancreas Cancer Vaccine 53 IAP inhibitor 53 Spiegelmer ® 53 compound perifosine 53 Pruvel TM 53 HCV RNA polymerase 53 Allovectin 7 53 selective antagonist 53 MKC# MT 53 MVA MUC1 IL2 53 selective kinase inhibitor 53 Monoclonal antibody 53 inhaled AAT 53 Cytochrome P# 53 nucleotide analog polymerase inhibitor 53 thrombopoietin TPO natural 53 investigational immunotherapy 53 ALTROPANE R 53 MOVIPREP R 53 potent suppressor 53 plasmid DNA 53 Panzem NCD 53 proteasome inhibitor 53 defensin mimetic antibiotic 53 using VIAdel TM 53 molecular imaging radiopharmaceutical 53 torezolid 53 aurora kinase inhibitor 53 CTLA4 53 hPTH #-# 53 Ecallantide 53 Vaxfectin formulated 53 anionic backbone 53 humanized therapeutic 53 Inc. NASDAQ AVII 53 calcitonin gene related 53 Dendritic Cells 53 tetravalent 53 acting neuraminidase inhibitor 53 oxazolidinone 53 M Vax 53 maturation inhibitor 53 SPL# Gel vaginal microbicide 53 systemic RNAi therapeutic 53 Fc fusion protein 53 radiolabelled 53 Toxoid 53 PEGylated Fab fragment 53 IMiDs ® 53 Initiated Phase 53 CholeraGarde R 52 Alferon N 52 Orally administered 52 virus AAV 52 investigational oral hepatitis C 52 initiated Phase Ib 52 OncoVex 52 OvaRex R 52 Personalized Immunotherapy 52 apoptosis inducers 52 subcutaneously administered 52 TKM Ebola 52 Cefazolin 52 Prodarsan R 52 Humanized Anti 52 Investigational Oral 52 NS5A 52 NS5b 52 intramuscular IM 52 pan HDAC inhibitor 52 adenovirus vector 52 immunoconjugate 52 unresectable inoperable 52 anti CD3 52 HyperAcute 52 potently inhibit 52 PDX pralatrexate 52 M2 subunit 52 anticancer compound 52 antisense oligonucleotide 52 selective modulator 52 vinca alkaloid 52 small molecule chemotherapeutic 52 immuno therapeutic 52 aurora kinase 52 investigational protease inhibitor 52 Anidulafungin 52 conserved antigens NP 52 histone deacetylase inhibitor 52 orally inhaled migraine 52 small molecule tyrosine 52 developing TB4 52 Oncolytic 52 antibody blinatumomab MT#/MEDI-# 52 imetelstat GRN#L 52 alvespimycin 52 TELINTRA R 52 HepDirect prodrug 52 TLR7 agonist 52 CRMD# 52 Intranasal 52 benzimidazole 52 inactivated influenza 52 vivo toxicology 52 virus HCV protease inhibitor 52 Imatinib mesylate 52 C1INH 52 Initiate Clinical Trial 51 inverse agonist 51 CEL SCI Phase III 51 induces antibodies 51 TransMID 51 Cotara ® 51 hypoxia activated prodrug 51 tumor vascular disrupting 51 histone deacetylase HDAC inhibitor 51 investigational integrase inhibitor 51 purified recombinant 51 telomerase activator 51 Camvia 51 exploratory Phase IIa 51 DPOLT 51 Mesylate 51 kappa B 51 REG2 51 Alfacell proprietary ribonuclease 51 investigational antiplatelet agent 51 proprietary polysaccharide 51 E2F 51 BT VACC TM 51 highly selective inhibitor 51 ABLYNX 51 selectively inhibited 51 receptor tyrosine kinase inhibitor 51 HCD# [002] 51 Ganciclovir 51 Phase Ib II 51 Aflibercept 51 Phase IIb III 51 Bosutinib 51 telaprevir VX 51 GW# [003] 51 Plasmid DNA 51 Begins Dosing 51 acyclovir Lauriad R 51 SMARTICLES ® 51 cGMP manufacture 51 Phase IIb clinical trials 51 RTP #i 51 dependent RNA polymerase 51 Recombinant Human 51 Cand5 51 Diamyd R 51 EGS# 51 gag pol 51 RhuDex ® 51 tissue transglutaminase 51 Aztreonam 51 metabolite profiling 51 Antisense Oligonucleotides 51 SynCon ™ DNA 51 Flt3 51 dasatinib Sprycel 51 NanoEmulsion 51 situ gelling 51 multicenter dose escalation 51 PSMA ADC 51 ADP receptor antagonist 51 peptide receptor 51 IMX# 51 Phase lll 51 polyglutamate 51 Initiates Clinical 50 muscarinic antagonist 50 TBC# 50 HEPLISAV TM hepatitis B 50 deacetylase 50 lorvotuzumab mertansine 50 ActA 50 Phase III confirmatory 50 Inhalation Powder 50 cyclin dependent kinase inhibitor 50 omacetaxine mepesuccinate 50 attach auristatin 50 hydroxamic acid 50 Phase 2b Clinical Trial 50 HCl capsules 50 Atripla combines 50 diphosphate 50 Aganocide ® 50 sterile lidocaine patch 50 intranasal insulin product 50 MANF 50 MorphoSys AG MOR GY 50 dependent protein kinase 50 Thiovir 50 Factor Receptor 50 darinaparsin ZIO 50 antimitotic 50 fludarabine phosphate 50 monoclonal antibody MAb 50 multicenter Phase II 50 treat secondary hyperparathyroidism 50 BIM #A# 50 IRDye 50 PANVAC VF 50 Plicera 50 Imvamune R 50 #I TM# 50 adenosine A2A 50 enkephalin 50 Hsp# Inhibitor 50 Polymerase Inhibitor 50 Achieves Primary Endpoint 50 Forodesine 50 randomized controlled Phase 50 Selective Inhibitor 50 Sphingomab TM 50 ibritumomab tiuxetan 50 small molecule inhibitor 50 long acting muscarinic 50 selective adenosine 50 AKT inhibitor 50 MAGE A3 ASCI 50 anti PlGF 50 inhibitor IPI 50 Protein Kinase C 50 glycopeptide 50 AVENTIS 50 monoclonal anti 50 Phase III multicenter 50 NTCD 50 CYP#A# CYP#D# 50 AMPK activators 50 purified inactivated 50 recombinant PSMA vaccine 50 Bacillus Calmette Guerin 50 Tubulin 50 oral treprostinil 50 PRN FDA Approves 50 Entry Inhibitor 50 novel prodrug 50 Enzastaurin 50 Phase Ib study 50 midstage trials 50 PI3K/Akt pathway inhibitor 50 Xcellerated T Cells 50 aspartyl 50 dihydrofolate reductase 50 ribonucleotide reductase 50 reversible inhibitor 50 accumulate preferentially 50 Angiotensin Converting Enzyme 50 PEG IFN 50 SURFAXIN r 50 phorbol 50 Presents Preclinical 50 Lactoferrin 50 adefovir dipivoxil 50 AMPA kainate 50 ToleroMune R 50 Dimebon latrepirdine 50 Orally Active 50 Tarsa oral calcitonin 50 murine monoclonal antibody 49 vapreotide acetate 49 HER1 49 nonhuman primate model 49 Prodarsan ® 49 microtubule inhibitor 49 Phase III ADT 49 Vidaza azacitidine 49 5 fluorouracil leucovorin 49 Phase 2a clinical trials 49 selective immunoproteasome inhibitor 49 soluble TNF receptor 49 Helixate R 49 peptide fragment 49 Phase III TRIST 49 selectin antagonist 49 Cytotoxic 49 fosbretabulin 49 UVIDEM 49 Fx #A 49 Piperacillin 49 Phase 1a clinical 49 kinase PI3K 49 Romidepsin 49 1beta 49 novel orally bioavailable 49 ZFP Therapeutics 49 initiate Phase 2b 49 Reductase 49 adrenoceptor 49 Kinoid 49 ONCONASE R 49 anti secretory 49 tolevamer 49 Adenoviral 49 integrin inhibitor 49 nasal spray formulation 49 cyclic peptide 49 assessing T DM1 49 PI3K/mTOR 49 stably transfected 49 Dalbavancin 49 Ostabolin C TM 49 Monoclonal 49 MVA HPV IL2 49 glycopeptide antibiotic 49 lipoglycopeptide 49 administered concomitantly 49 Gentamicin Surgical Implant 49 pharmacologically active isomer 49 Files IND 49 methylnaltrexone bromide 49 transmucosal delivery system 49 selective serotonin 2C receptor 49 Luramist 49 retaspimycin 49 StemEx 49 highly selective endothelin 49 novel antifolate 49 intra nasal 49 Reports Preclinical Data 49 Phase IIa proof 49 urate oxidase 49 FDA APPROVES 49 multicenter Phase 49 IND submission 49 anthracycline derivative 49 lamivudine resistant 49 potent anticancer 49 GMX# 49 prepandemic 49 TLR9 agonists 49 Hypoxia inducible factor 49 BrachySil TM 49 Belerofon 49 Genotyping Test 49 topical gel formulation 49 Conjugate 49 administered subcutaneously 49 Emtriva Viread 49 CCR5 antagonist 49 Mipomersen 49 novel defensin mimetic 49 oral PTH 49 Harry Palmin President 49 4E BP1 49 topical lotion 49 EliA 49 lysate 49 IIa trial 49 dasatinib Sprycel ® 49 Darinaparsin 49 HuMax EGFr 49 ospemifene 49 microsomal 49 #mg/#mg 49 selective phosphodiesterase 49 Receives Orphan Drug Designation 49 Glucan 49 CDK inhibitor 49 Trastuzumab DM1 49 gets USFDA nod 49 Glycosylation 49 astemizole 49 immunodominant 49 Indomethacin 49 immune globulin intravenous 49 intravesical instillation 49 Fodosine 49 pyruvate kinase 49 IMiD 49 solithromycin 49 cetuximab Erbitux R 49 Vicriviroc 49 L alanine 49 fusion protein 49 protein secreted 49 oral opioid modulator 49 mediated phosphorylation 49 Polymerase 49 potent activator 49 secretagogues 49 novel synthetic peptide 49 Ziprasidone 49 metformin XR 49 Testosterone MDTS ® 49 Intravitreal 49 tolerogenic 49 thymidylate synthase TS 49 Indibulin ZIO 49 human IgG1 49 aldehyde dehydrogenase ALDH2 deficiency 49 HCV replicon 49 Transgene therapeutic 48 SensoLyte 48 TNF Tumor Necrosis Factor 48 Upregulation 48 PEGylated anti 48 AEG# 48 LBH# 48 mediated inhibition 48 lexidronam injection 48 PN# [001] 48 Phase #b/#a trial 48 multikinase inhibitor 48 cyclase 48 histone acetyltransferase 48 R Saizen R 48 Chinese Hamster Ovary 48 PLA2 48 Immunoglobulin G 48 topical ophthalmic 48 ACAPODENE TM 48 3 registrational trial 48 LEAD Therapeutics 48 nucleotide analog 48 Diamyd ® 48 Prodrug 48 pan genotypic 48 Initiates Enrollment 48 serine threonine kinase 48 Bazedoxifene 48 anaplastic lymphoma kinase ALK 48 inhibit viral replication 48 Xeloda ® 48 p# alpha [001] 48 Tumor necrosis factor 48 targeting PCSK9 48 trastuzumab DM1 48 Vitrasert R 48 Macrolide 48 antibody binds 48 GLP1 agonist 48 registrational Phase 48 Akt inhibitor 48 Hedgehog antagonist 48 EVIZON ™ 48 cephalosporin antibiotic 48 torezolid phosphate 48 lidocaine hydrochloride monohydrate powder 48 generation Hsp# inhibitor 48 Isavuconazole 48 Phase Ia 48 antisense inhibitors 48 SR# [004] 48 Streptococcus pneumoniae serotypes 48 miconazole Lauriad ® 48 Silodosin 48 ABthrax raxibacumab 48 overactive bladder AA# 48 PrevOnco ™ 48 generation URAT1 inhibitor 48 p# MAP kinase inhibitor 48 glycogen synthase kinase 48 Phase 2b clinical trials 48 include Phenoptin TM 48 Collategene 48 receptor blocker 48 ceftazidime 48 DEEP AF 48 Terbinafine 48 PI3 K 48 hypereosinophilic syndrome 48 Rimantadine 48 SPRYCEL ® 48 Phase 1b trial 48 triggers apoptosis programmed 48 RhuDex R 48 FUS1 48 IND Application 48 Omacetaxine 48 neuraminidase NA 48 Mg Usa 48 capsules USP 48 itraconazole Sporanox 48 phase Ib 48 selectively inhibit 48 essential thrombocythemia ET 48 controlled multicenter Phase 48 covalently bound 48 Drug Candidate 48 Sustiva efavirenz 48 triciribine phosphate monohydrate 48 initiate Phase IIa 48 hemagglutinin H 48 mitogen activated protein 48 peripherally acting 48 NurOwn 48 retinoic acid receptor 48 potent antiproliferative 48 ritonavir boosted danoprevir 48 BENLYSTA ™ 48 Prodarsan 48 NASH Huntington 48 phase IIb III 48 selective A2A adenosine receptor 48 multicenter phase 47 alpha subunit 47 estradiol transdermal spray 47 OLpur TM H2H 47 Phase Ib IIa 47 Respiratory Virus 47 evaluating tivozanib 47 inhibitor COX 47 ,#,# [002] 47 transduced 47 glucokinase 47 prolyl 47 Tarvacin Anti Cancer 47 Immune Globulin Human 47 Isis antisense 47 Mucosal 47 Telatinib 47 IMC #F# 47 R#/MEM # 47 generation cephalosporin antibiotic 47 Medoxomil 47 targeted nucleotide prodrug 47 N acetylgalactosamine 47 SinuNase ™ 47 converting enzyme 47 potent stimulator 47 microsomal triglyceride transfer 47 Zemiva TM 47 phase Ib clinical 47 NOVARTIS 47 proteinase 47 NOX E# 47 Posaconazole 47 Phase #b/#a 47 Archexin 47 Bioral Amphotericin B 47 RESTORE CLI trial 47 quinoline 47 Oxytrex TM 47 BioFocus DPI Galapagos 47 Genentech Rituxan 47 cytomegalovirus immune globulin 47 Mycophenolate Mofetil 47 cromolyn sodium 47 Integrase Inhibitor 47 pertussis toxin 47 assay detects 47 implantable glucose sensor 47 levoleucovorin 47 thalidomide Thalomid 47 novel emulsion formulation 47 Unitract ™ 47 nicotinamide adenine dinucleotide 47 Gemzar gemcitabine 47 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 47 activin receptor type 47 plasmids encoding 47 Alkeran 47 adalimumab Humira 47 Therapeutic Competitors Companies 47 tocopheryl acetate 47 Lentiviral 47 Phase #/#a clinical 47 generation PNP inhibitor 47 ficlatuzumab 47 romidepsin novel 47 Phase 1a 47 Interferon beta 1a 47 bevacizumab Avastin R 47 Phase IIA 47 using Innocoll proprietary 47 oral nucleoside analogue 47 Protease 47 uroguanylin 47 treats acute lymphoblastic 47 broad spectrum cephalosporin 47 canagliflozin 47 Solorel 47 Retisert R 47 Phase III Pivotal 47 Receives Approvable Letter 47 peptide CGRP 47 PEG Interferon 47 gamma secretase inhibitor 47 Urocidin 47 nicotinic acetylcholine receptor 47 SUCCEED trial 47 peroxidase 47 Leukine ® 47 Histone 47 dose escalation Phase 47 oral anti arrhythmic 47 tyrosine kinase receptor 47 refractory gastrointestinal stromal 47 kDa protein 47 biotinylated 47 muscarinic receptor agonist 47 Pegloticase 47 antitrypsin 47 Transdermal System 47 dihydrochloride 47 hydroxypropyl 47 fidaxomicin Phase 3 47 5alpha reductase 47 Biopharmaceuticals AG 47 HDACi 47 Dose Ranging Study 47 alefacept 47 AERAS-#/Crucell Ad# 47 Adnectin 47 IMC #B 47 Irinotecan 47 capsular polysaccharide 47 phosphoprotein 47 Bayer HealthCare Onyx Pharmaceuticals 47 osteoprotegerin 47 induces apoptosis 47 auristatin 47 Shp2 47 rALLy clinical trial 47 hydroxocobalamin 47 thymidine kinase 47 patented DepoVax ™ 47 Melphalan 47 Hsp# chaperone inhibitor 47 Hemopurifier ® 47 sNDA submission 47 Antiarrhythmic 47 octreotide acetate 47 Ph2 47 subcutaneous PRO 47 NS5B 47 Associated Diarrhea 47 methyl CpG binding 47 metalloproteinase 47 DGAT1 47 recombinantly 47 adrenoceptor agonist 47 ® bortezomib 47 receptor ligand 47 Initiates Phase 2b 47 metastatic colorectal carcinoma 47 Photodynamic 47 SNT MC# 47 assay kits 46 Pathway Inhibitor 46 Phase Ib clinical 46 CpG ODNs 46 PPAR gamma agonist 46 Radezolid 46 defensin 46 factor TNF 46 HDL mimetic 46 2 methoxyestradiol 46 delta opioid receptor 46 etanercept Enbrel 46 anti infective treatments 46 Phase Ib clinical trials 46 inducible 46 abacavir Ziagen 46 Phase 2a proof 46 Nitazoxanide 46 ErbB3 46 ara C 46 Roflumilast 46 hydrolase 46 mGluR 46 including eniluracil ADH 46 adipogenic 46 combines bupropion 46 lipase inhibitor 46 Fludase 46 Occlusin TM 46 ERK pathway 46 fumarate 46 NS#/#A protease 46 Surfaxin LS 46 hepatitis B vaccine Heplisav 46 protein tyrosine 46 inhibits VEGF 46 phosphoinositide 46 parenterally administered 46 polyketide 46 experimentally validated 46 particle VLP vaccine 46 enzymatically active 46 leading oral taxane 46 Phase 1b clinical 46 imatinib Gleevec ® 46 glyco 46 Cyclosporin 46 gemcitabine Gemzar ® 46 cyclophosphamide vincristine 46 peptides proteins 46 Modulates 46 Ropinirole 46 Lauriad ® 46 Cyclin E 46 anti HGF antibody 46 annexin 46 Zemplar Capsules 46 metastatic malignant 46 Alzhemed TM 46 carmustine 46 Biolimus A9 46 oral taxane 46 bardoxolone 46 phase IIb clinical 46 Lenocta TM 46 WX UK1 46 HCV Genotype 46 Taq polymerase 46 HEK# 46 thyroid hormone receptor 46 5 HT4 receptor 46 brivanib 46 Daptomycin 46 enzyme metabolizes 46 Chroma Therapeutics 46 norfloxacin 46 redox active 46 proprietary radiolabeled monoclonal 46 AZD# ARRY # 46 PAM4 46 receptor antagonism 46 Acetavance TM intravenous acetaminophen 46 Initiates Clinical Trial 46 5 Fluorouracil 46 IND enabling 46 extracellular domain 46 randomized discontinuation 46 serine protease inhibitor 46 glucosidase 46 Shows Statistically Significant 46 cytoplasmic domain 46 Levoleucovorin 46 FDA Accepts 46 containing abacavir 46 CG# [003] 46 concomitantly administered 46 Sandimmune 46 RhuDex TM 46 adrenergic receptor agonist 46 semi synthetic lipoglycopeptide 46 ThGRF 46 affinity ligands 46 lyase 46 ALVESCO ® 46 alferminogene tadenovec 46 Replacement Therapy 46 mg kg BID 46 synthesizing enzyme 46 Transdermal Patch 46 QNEXA ® 46 RNAI 46 glucocerebrosidase 46 SCD1 46 NKX#.# 46 antiapoptotic 46 chemically modify 46 siderophore 46 antiarrhythmic agent 46 administered intranasally 46 deaminase 46 injectable investigational 46 downregulates 46 Glycoprotein 46 Genz # 46 clinical trials Archexin 46 Valproic acid 46 PHARM 46 Mitomycin 46 deforolimus 46 Senetek patented 46 Ph + chronic myeloid 46 NADiA ProsVue 46 balsalazide disodium Capsules 46 GALNS 46 initiate Phase Ib 46 tinidazole 46 geldanamycin 46 atazanavir Reyataz 46 vesicular stomatitis virus 46 Phase 2a trial 46 candidate brentuximab vedotin 46 antibiotic amikacin 46 tetracycline antibiotic 46 phase IIb 45 Adeno 45 Transcription Factor 45 1α 45 Flavivirus 45 nucleoprotein 45 antagonist LAMA 45 Emtriva emtricitabine 45 abacavir lamivudine 45 registrational trial 45 Immunomodulatory 45 beta lactam 45 FOXO3a 45 Submits Investigational 45 VISICOL R 45 HIF 1α 45 Darusentan 45 Peptide 45 IgM antibodies 45 ChronVac C ® 45 Nucleotides 45 CTAP# Injection 45 phase III isavuconazole 45 HCV polymerase inhibitors 45 mediated apoptosis 45 secretase 45 Maleate 45 evolutionary conserved 45 BUPHENYL R sodium phenylbutyrate 45 IgM antibody 45 3 kinase PI3K 45 Ozarelix 45 topical ocular 45 Ofloxacin 45 Crucell genetically engineered 45 Lanthanum carbonate 45 Therapeutic Competitors Report 45 ciprofloxacin hydrochloride 45 HCl Injection 45 DNA gyrase 45 arginine vasopressin AVP 45 PTK# 45 Protein Kinase 45 synthase TS 45 treat chronic sinusitis 45 decarboxylase 45 Prolastin C 45 Muraglitazar 45 Raf kinase inhibitor 45 thermostable 45 Methionine 45 topical antifungal 45 Tezampanel 45 Plavix clopidogrel bisulfate 45 pharmacophore 45 phase IIa clinical 45 fluticasone furoate 45 Unifill TM syringe 45 purified protein 45 Phase 2a preventative 45 using BioSante patented 45 Histone deacetylase 45 TRELSTAR R LA 45 indinavir Crixivan 45 investigational hepatitis C 45 Attenuated 45 confirmatory pivotal 45 LCP AtorFen 45 Viread tenofovir disoproxil fumarate 45 oral beclomethasone dipropionate 45 LibiGel testosterone gel 45 phase IIb study 45 phase IIa 45 daptomycin 45 BLA filing 45 BMAL1 45 tezampanel NGX# 45 ghrelin receptor 45 antimicrobial peptide 45 Stimuvax R 45 gamma glutamyl 45 IIb clinical trial 45 Rifampicin 45 ALN VSP Phase 45 ERK1 2 45 cyclic nucleotide 45 AeroLEF TM 45 Announces Tentative Approval 45 initiate Phase 1b 45 GPI anchored 45 apoptosis inducing 45 inhibitor VX 45 Phase III registrational 45 ketolide 45 sunitinib Sutent ® 45 inhibits protein synthesis 45 CHO cells